Reprieve Cardiovascular, Inc
Clinical trials sponsored by Reprieve Cardiovascular, Inc, explained in plain language.
-
New device aims to safely drain fluid in heart failure patients
Disease control Recruiting nowThis Phase 3 trial tests the Reprieve System, a bedside device that automatically adjusts diuretic and saline infusion based on a patient's urine output, to treat acute decompensated heart failure. Researchers will compare it to standard diuretic therapy in 400 hospitalized adult…
Phase: PHASE3 • Sponsor: Reprieve Cardiovascular, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New device automates fluid removal to ease heart failure symptoms
Symptom relief Recruiting nowThis pilot study tests the Reprieve System, a bedside device that automatically adjusts the delivery of a diuretic (furosemide) and saline based on the patient's real-time urine output. The goal is to safely and quickly remove excess fluid from 50 hospitalized adults with acute d…
Phase: NA • Sponsor: Reprieve Cardiovascular, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC